Vincristine Sulfate Injection 2 mg in 2 mL (3)

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

vincristine sulfate, Quantity: 1 mg/mL

Tilgængelig fra:

Pfizer (Perth) Pty Ltd

Lægemiddelform:

Injection, solution

Sammensætning:

Excipient Ingredients: mannitol; sulfuric acid; water for injections; sodium hydroxide

Indgivelsesvej:

Intravenous

Enheder i pakken:

1 x 2 mL

Recept type:

(S1) This Schedule is intentionally blank

Terapeutiske indikationer:

Acute leukaemia. In combination with other cytostatic drugs for Hodgkin's disease, lymphosarcoma, reticulocyte sarcoma, rhabdomyosarcoma, neuroblastoma, and Wilms' tumour.

Produkt oversigt:

Visual Identification: Clear and colourless solution; Container Type: Vial; Container Material: PP; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisation status:

Listed (Export Only)

Autorisation dato:

2019-10-15